13FPulse
中
IB

IBRX IMMUNITYBIO INC

2026Q2 · CUSIP 45256X103 · Sector: Healthcare & Biotech

Cooling

Net holder growth weakened from last quarter

Funds that own it
394
Institutions that reported holding it to the SEC
Net increase in holders
+11
Last quarter 383 → now 394
How unusual is that
Above average
Stronger buying than 71% of US stocks
What the filings say, in one paragraph

394 funds held IBRX at the end of 2026Q2, up 11 from the quarter before. Buying has come off its highs, but funds are not exiting. On the business itself, revenue over the last 12 months was $166M(YoY +192.9%). IBRX has had 6 buying rushes in its history, and the price moved +126.0% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2021Q2: holders=116 2021Q3: holders=119 2021Q4: holders=139 2022Q1: holders=148 2022Q2: holders=131 2022Q3: holders=124 2022Q4: holders=140 2023Q1: holders=146 2023Q2: holders=116 2023Q3: holders=130 2023Q4: holders=147 2024Q1: holders=165 2024Q2: holders=194 2024Q3: holders=181 2024Q4: holders=202 2025Q1: holders=210 2025Q2: holders=241 2025Q3: holders=263 2025Q4: holders=275 2026Q1: holders=383 2026Q2: holders=394 -108 -54 +0 +54 +108 104259414 21Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 6 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 5% — —
2025Q3 Top 20% +324.1% +296.6%
2025Q2 Top 10% -14.4% +251.4%
2024Q2 Top 10% +21.4% -2.7%
2024Q1 Top 20% -47.7% -41.3%
2023Q3 Top 20% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
160
Change in large funds
+13
Total value they hold
$1.8B
Funds buying for the first time
67
Funds that sold out entirely
56
Price change that quarter
-0.6%
Funds holding puts (bearish)
15
Funds holding calls (bullish)
19

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.97
EPS YoY
—
Revenue (TTM)
$0.2B
Revenue YoY
+192.9%
Net margin
—
ROE
—
Debt ratio
—
FCF (TTM)
-$288M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.22 2021-12-31: EPS -0.23 2022-03-31: EPS -0.26 2022-06-30: EPS -0.24 2022-09-30: EPS -0.28 2022-12-31: EPS -0.26 2023-03-31: EPS -0.27 2023-06-30: EPS -0.32 2023-09-30: EPS -0.19 2023-12-31: EPS -0.37 2024-03-31: EPS -0.20 2024-06-30: EPS -0.20 2024-09-30: EPS -0.14 2024-12-31: EPS -0.08 2025-03-31: EPS -0.15 2025-06-30: EPS -0.10 2025-09-30: EPS -0.07 2025-12-31: EPS -0.06 2026-03-31: EPS -0.62 2026-06-30: EPS -0.22 0M 26M 51M $M -0.68 -0.34 0.00 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-123M-62M0K 20162017201820192020202120222023202420252026
Latest quarter $-77M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.